The hunt for the next antibiotics

· Source: Machine learning : nature.com subject feeds · Field: Health & Wellbeing — Public Health & Epidemiology, Pharmaceuticals & Biotechnology · Depth: Novice, quick

Summary

Antimicrobial resistance is causing antibiotics to lose effectiveness, posing a significant threat to routine medical treatments like cancer care, newborn care, and surgery due to increased infection risks. Millions are already succumbing to resistant bacterial infections, and the World Bank projects healthcare costs could rise by US$1 trillion by 2050. Researchers are actively seeking solutions, exploring diverse avenues from extremophile organisms and traditional folk medicine to the grave of a faith healer. Additionally, artificial intelligence is being employed to accelerate antibiotic discovery, improve drug delivery into bacteria, and guide physicians in appropriate antibiotic prescription to combat overuse.

Key takeaway

For healthcare policymakers and pharmaceutical researchers, the escalating crisis of antimicrobial resistance demands immediate, multi-faceted action. Prioritize funding for novel antibiotic discovery, including unconventional sources and AI-driven approaches, while simultaneously implementing strategies to optimize existing antibiotic use to preserve their efficacy and prevent a future resurgence of bacterial infections.

Key insights

Antimicrobial resistance threatens global health, necessitating urgent, diverse research into new antibiotics and resistance mitigation.

Principles

Method

Researchers are investigating extremophile organisms, traditional medicine, and leveraging AI for antibiotic discovery, delivery, and prescription guidance to extend drug efficacy.

In practice

Topics

Best for: Research Scientist, Domain Expert, AI Scientist

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.